Peripheral Neuropathy News and Research

RSS
Peripheral neuropathy describes damage to the peripheral nervous system, which transmits information from the brain and spinal cord to every other part of the body.

More than 100 types of peripheral neuropathy have been identified, each with its own characteristic set of symptoms, pattern of development, and prognosis. Impaired function and symptoms depend on the type of nerves -- motor, sensory, or autonomic -- that are damaged. Some people may experience temporary numbness, tingling, and pricking sensations, sensitivity to touch, or muscle weakness. Others may suffer more extreme symptoms, including burning pain (especially at night), muscle wasting, paralysis, or organ or gland dysfunction. Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, and vascular and metabolic disorders. Acquired peripheral neuropathies are caused by systemic disease, trauma from external agents, or infections or autoimmune disorders affecting nerve tissue. Inherited forms of peripheral neuropathy are caused by inborn mistakes in the genetic code or by new genetic mutations.
Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Angiochem presents results of Phase 2 study with ANG1005 in breast cancer patients with brain metastases

Angiochem presents results of Phase 2 study with ANG1005 in breast cancer patients with brain metastases

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

FDA approves Cimzia for treatment of adults with active ankylosing spondylitis

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

FDA approves Cimzia (certolizumab pegol) for active psoriatic arthritis

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Dog food preservative may prevent nerve damage in patients taking chemotherapy

Dog food preservative may prevent nerve damage in patients taking chemotherapy

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

FDA approves use of abraxane to treat patients with late-stage pancreatic cancer

Targeted Medical Pharma launches new division to manufacture and distribution dietary supplements

Targeted Medical Pharma launches new division to manufacture and distribution dietary supplements

Ohio State's Wexner Medical Center neurosurgeons implant MRI-safe spinal cord stimulator for pain

Ohio State's Wexner Medical Center neurosurgeons implant MRI-safe spinal cord stimulator for pain

NeuroMetrix announces business and financial highlights for second quarter

NeuroMetrix announces business and financial highlights for second quarter

FDA takes action to remove illegal diabetes products from market

FDA takes action to remove illegal diabetes products from market

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Pitt researchers propose mathematical model that examines multiple walking patterns in older adults

Pitt researchers propose mathematical model that examines multiple walking patterns in older adults

First consensus guidelines for use of neurostimulation in chronic pain

First consensus guidelines for use of neurostimulation in chronic pain

Patented nicotinamide riboside launched by Chromadex

Patented nicotinamide riboside launched by Chromadex

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

Study: Combination of chemotherapy and nerve-protecting agents can prevent anemia

New FDA-approved method for detecting diabetic neuropathy

New FDA-approved method for detecting diabetic neuropathy